An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical Antipsychotics
NCT ID: NCT00448630
Last Updated: 2022-05-03
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
328 participants
OBSERVATIONAL
2007-10-23
2008-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Monitoring and Management for Metabolic Side Effects of Antipsychotics
NCT01875861
Antipsychotics and Metabolic Syndrome
NCT00636753
β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS
NCT00528359
Alleviating the Metabolic Side Effects of Antipsychotic Medications
NCT01567124
One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome
NCT00748566
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Atypical Antispychotics (or second generation antipsychotics)
Patients with schizophrenia who are currently receiving or are going to start a new treatment with atypical antipsychotics, ziprasidone, risperidone, quetiapine, olanzapine, aripiprazole, amisulpride.
No intervention
Non-interventional study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
Non-interventional study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18-45 years
* Patients who started atypical antipsychotic drug treatment or patients who switched from the previous conventional or atypical antipsychotic treatment to another atypical antipsychotic drug treatment by the decision of their physicians.
Exclusion Criteria
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Adana Psychiatry and Neurology Hospital
Kurttepe, Adana, Turkey (Türkiye)
Pfizer Investigational Site
Kurttepe, Adana, Turkey (Türkiye)
Adana Psychiatry and Neurology Hospital
Adana, , Turkey (Türkiye)
Cukurova University Scool of Medicine
Adana, , Turkey (Türkiye)
Pfizer Investigational Site
Adana, , Turkey (Türkiye)
Ankara Oncology Research and Training Hospital
Ankara, , Turkey (Türkiye)
Pfizer Investigational Site
Ankara, , Turkey (Türkiye)
Ankara Diskapi Training and Research Hospital
Ankara, , Turkey (Türkiye)
Ankara Numune Research Hospital
Ankara, , Turkey (Türkiye)
Ankara Numune Training and Research Hospital Department of Psychiatry
Ankara, , Turkey (Türkiye)
Pfizer Investigational Site
Ankara, , Turkey (Türkiye)
Antakya Mustafa Kemal University School of Medicine
Antakya, , Turkey (Türkiye)
Pfizer Investigational Site
Antakya, , Turkey (Türkiye)
Bolu Psychiatry and Neurology Hospital
Bolu, , Turkey (Türkiye)
Pfizer Investigational Site
Bolu, , Turkey (Türkiye)
Pamukkale University School Of Medicine
Denizli, , Turkey (Türkiye)
Pfizer Investigational Site
Denizli, , Turkey (Türkiye)
Elazig Mental Illness And Diseases Hospital
Elâzığ, , Turkey (Türkiye)
Pfizer Investigational Site
Elâzığ, , Turkey (Türkiye)
Eskisehir Osmangazi University
Eskişehir, , Turkey (Türkiye)
Pfizer Investigational Site
Eskişehir, , Turkey (Türkiye)
Bakirkoy Psychiatry and Neurology Hospital
Istanbul, , Turkey (Türkiye)
Pfizer Investigational Site
Istanbul, , Turkey (Türkiye)
Bakirkoy Mental Health Hospital, First Clinic of Neurosis
Istanbul, , Turkey (Türkiye)
Bakirkoy Psychiatry and Neurology Hospital
Istanbul, , Turkey (Türkiye)
Cerrahpasa School of Medicine
Istanbul, , Turkey (Türkiye)
Erenkoy Psychology and neurology hospital
Istanbul, , Turkey (Türkiye)
Istanbul University Istanbul School of Medicine
Istanbul, , Turkey (Türkiye)
Marmara School of Medicine
Istanbul, , Turkey (Türkiye)
Pfizer Investigational Site
Istanbul, , Turkey (Türkiye)
Sisli Etfal Research and training Hospital
Istanbul, , Turkey (Türkiye)
Vakif Gureba Hospital, Department of Psychiatry
Istanbul, , Turkey (Türkiye)
Ege University School Of Medicine
Izmir, , Turkey (Türkiye)
Pfizer Investigational Site
Izmir, , Turkey (Türkiye)
Kayseri Public Hospital
Kayseri, , Turkey (Türkiye)
Pfizer Investigational Site
Kayseri, , Turkey (Türkiye)
Pfizer Investigational Site
Konya, , Turkey (Türkiye)
Selcuk University Medical School Department of Psychiatry
Konya, , Turkey (Türkiye)
Manisa Mental Illness And Diseases Hospital
Manisa, , Turkey (Türkiye)
Pfizer Investigational Site
Manisa, , Turkey (Türkiye)
19 may University School of Medicine
Samsun, , Turkey (Türkiye)
Pfizer Investigational Site
Samsun, , Turkey (Türkiye)
Samsun Mental Illness And Diseases Hospital
Samsun, , Turkey (Türkiye)
Pfizer Investigational Site
Trabzon, , Turkey (Türkiye)
Trabzon Numune Research Hospital
Trabzon, , Turkey (Türkiye)
Pfizer Investigational Site
Trakya, , Turkey (Türkiye)
Trakya University School of Medicine
Trakya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A1281160
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.